Loxo Oncology (LOXO) Reports Q3 Loss of $2.26/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts LOXO Hot Sheet
Join SI Premium – FREE
Loxo Oncology (NASDAQ: LOXO) reported Q3 EPS of ($2.26), versus ($0.94) reported last year. Revenue for the quarter came in at $42.5 million, versus $0 reported last year.
For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood shares fall on Q3 revenue miss even as EPS beats
- Highwoods Properties (HIW) Tops Q3 EPS by 7c
- NXP Semiconductors (NXPI) Tops Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
